A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity - PubMed (original) (raw)
A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity
Martin Kühne et al. Cancer Res. 2004.
Abstract
The ATM protein, which is mutated in individuals with ataxia telangiectasia (AT), is central to cell cycle checkpoint responses initiated by DNA double-strand breaks (DSBs). ATM's role in DSB repair is currently unclear as is the basis underlying the radiosensitivity of AT cells. We applied immunofluorescence detection of gamma-H2AX nuclear foci and pulsed-field gel electrophoresis to quantify the repair of DSBs after X-ray doses between 0.02 and 80 Gy in confluence-arrested primary human fibroblasts from normal individuals and patients with mutations in ATM and DNA ligase IV, a core component of the nonhomologous end-joining (NHEJ) repair pathway. Cells with hypomorphic mutations in DNA ligase IV exhibit a substantial repair defect up to 24 h after treatment but continue to repair for several days and finally reach a level of unrepaired DSBs similar to that of wild-type cells. Additionally, the repair defect in NHEJ mutants is dose dependent. ATM-deficient cells, in contrast, repair the majority of DSBs with normal kinetics but fail to repair a subset of breaks, irrespective of the initial number of lesions induced. Significantly, after biologically relevant radiation doses and/or long repair times, the repair defect in AT cells is more pronounced than that of NHEJ mutants and correlates with radiosensitivity. NHEJ-defective cells analyzed for survival following delayed plating after irradiation show substantial recovery while AT cells fail to show any recovery. These data argue that the DSB repair defect underlies a significant component of the radiosensitivity of AT cells.
Similar articles
- The controlling role of ATM in homologous recombinational repair of DNA damage.
Morrison C, Sonoda E, Takao N, Shinohara A, Yamamoto K, Takeda S. Morrison C, et al. EMBO J. 2000 Feb 1;19(3):463-71. doi: 10.1093/emboj/19.3.463. EMBO J. 2000. PMID: 10654944 Free PMC article. - Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells.
Wang H, Zeng ZC, Perrault AR, Cheng X, Qin W, Iliakis G. Wang H, et al. Nucleic Acids Res. 2001 Apr 15;29(8):1653-60. doi: 10.1093/nar/29.8.1653. Nucleic Acids Res. 2001. PMID: 11292837 Free PMC article. - The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax.
Goodarzi AA, Jeggo P, Lobrich M. Goodarzi AA, et al. DNA Repair (Amst). 2010 Dec 10;9(12):1273-82. doi: 10.1016/j.dnarep.2010.09.013. Epub 2010 Oct 30. DNA Repair (Amst). 2010. PMID: 21036673 Review. - Mechanisms of DNA double strand break repair and chromosome aberration formation.
Iliakis G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, Wu W, Guan J, Terzoudi G, Pantelias G. Iliakis G, et al. Cytogenet Genome Res. 2004;104(1-4):14-20. doi: 10.1159/000077461. Cytogenet Genome Res. 2004. PMID: 15162010 Review.
Cited by
- Tissue microarray analyses of the essential DNA repair factors ATM, DNA-PKcs and Ku80 in head and neck squamous cell carcinoma.
Zech HB, von Bargen C, Oetting A, Möckelmann N, Möller-Koop C, Witt M, Struve N, Petersen C, Betz C, Rothkamm K, Münscher A, Clauditz TS, Rieckmann T. Zech HB, et al. Radiat Oncol. 2024 Oct 30;19(1):150. doi: 10.1186/s13014-024-02541-3. Radiat Oncol. 2024. PMID: 39478631 Free PMC article. - Primary Immunodeficiency-Type Ataxia-Telangiectasia Revealed by Splenic Abscesses.
Bebana A, Ghanam A, Tkak H, Elouali A, Babakhouya A, Rkain M. Bebana A, et al. Cureus. 2024 Jul 15;16(7):e64595. doi: 10.7759/cureus.64595. eCollection 2024 Jul. Cureus. 2024. PMID: 39149652 Free PMC article. - Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study.
Raychaudhuri R, Mo G, Tuchayi AM, Graham L, Gulati R, Pritchard CC, Haffner MC, Yezefski T, Hawley JE, Cheng HH, Yu EY, Grivas P, Montgomery RB, Nelson PS, Chen DL, Hope T, Iravani A, Schweizer MT. Raychaudhuri R, et al. JCO Precis Oncol. 2024 Apr;8:e2300634. doi: 10.1200/PO.23.00634. JCO Precis Oncol. 2024. PMID: 38662984 - Moving the Needle Forward in Genomically-Guided Precision Radiation Treatment.
Tam A, Mercier BD, Thomas RM, Tizpa E, Wong IG, Shi J, Garg R, Hampel H, Gray SW, Williams T, Bazan JG, Li YR. Tam A, et al. Cancers (Basel). 2023 Nov 7;15(22):5314. doi: 10.3390/cancers15225314. Cancers (Basel). 2023. PMID: 38001574 Free PMC article. Review. - DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy.
Obata H, Ogawa M, Zalutsky MR. Obata H, et al. Pharmaceutics. 2023 Jul 11;15(7):1926. doi: 10.3390/pharmaceutics15071926. Pharmaceutics. 2023. PMID: 37514113 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous